"Formerly California Oncology of the Central Valley, office of Dr. Chris Perkins. We are the only breast and gynecologic cancer specialists between San Francisco and Los Angeles. Our specialty allows us to address the unique needs of women facing a cancer diagnosis, but our emphasis on individual wholeness is what truly sets us apart. We build personal relationships with our patients, learning about family, friends, work, passions, and struggles so that every aspect can inform their treatment plan."

During the past decade, Women's Cancer Research Network conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Women's Cancer Research Network" are "Advanced Solid Tumor" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Endometrial Neoplasms" (1 trials), "Fallopian Tube Cancer" (1 trials) and "High Grade Ovarian Cancer" (1 trials). Many other conditions were trialed in "Women's Cancer Research Network" in a lesser frequency.

Most popular intervention types in "Women's Cancer Research Network" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Insulin Suppressing Diet" (1 trials), "Magrolimab" (1 trials), "Mirvetuximab soravtansine" (1 trials) and "Nab paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Women's Cancer Research Network" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Women's Cancer Research Network". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Women's Cancer Research Network, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Women's Cancer Research Network, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".